![David Goldstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Goldstein
Corporate Officer/Principal at International Society for Pharmacoeconomics & Outcomes Rsch
Net worth: 3 M $ as of 2024-05-30
Profile
David M.
Goldstein has worked as a Meetings Manager at the International Society for Pharmacoeconomics & Outcomes Research since 2012.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
Alumis, Inc.
![]() Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. 0.38% | 2024-06-30 | 216,897 ( 0.38% ) | 3 M $ | 2024-05-30 |
David Goldstein active positions
Companies | Position | Start |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
- Stock Market
- Insiders
- David Goldstein